Why didn’t nonprofits and the NIH require ‘reasonable’ pricing for Zolgensma? That may happen in France
(By James Love for STAT) When a new drug emerges from research largely funded by grants from charities and government
Read More
Part D/Prescription Drugs
Inspector general: Part D rebates grew, but not enough to offset drug price hikes
(By Maia Anderson for Becker’s Hospital Review) Although rebates for brand-name drugs in Medicare Part D substantially reduced drug spending,
Read MoreWhat if the U.S. adopts price controls on drugs?
In Doug Badger, senior fellow at the Galen Institute, opinion column published by The Daily Signal, writes how according to
Read MoreTake care to meet these Medicare deadlines
Most people sign up for Medicare during the three months prior, the month of or three months after their 65th
Read MoreWidespread use of 4 antibiotics tied to higher C. diff risk, study finds
(By Mackenzie Bean for Becker’s Hospital Review) Facilitywide use of four antibiotic classes is linked to a higher risk of Clostridium
Read MoreAre you ill-informed about Medicare?
A recent survey by Nationwide found a major knowledge gap on Medicare. The survey found a surprising 79 percent of
Read MorePurdue Pharma, Accused Of Fueling Opioid Crisis, Files For Chapter 11
(By Bobby Allyn for NPR) Purdue Pharma, the maker of OxyContin, filed for Chapter 11 bankruptcy protection Sunday night, just
Read MorePurveyors Of Black-Market Pharmaceuticals Target Immigrants
(By John M. Gionna for Kaiser Health News) The bootleg medications were smuggled across the border and sold to mostly
Read MoreHow Are Drug Prices Determined?
According to Rx Savings Solutions, a consulting firm for health insurance plans and employers, found in the first half of
Read MoreShould we be looking at Germany to reduce drug prices
As American lawmakers attempt to stem spiraling drug costs, they might find inspiration in Germany, where the government’s regulatory model
Read More